Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer

Journal of the National Cancer Institute

Volumn 91, Issue 4, 1999, Pages 354-359

  Bracke, Marc E ^a   Depypere, Herman T ^a   Boterberg, Tom ^a   Van Marck, Veerle L ^a   Vennekens, Krist'l M ^a   Vanluchene, Eric ^b   Nuytinck, Margareta ^b   Serreyn, Rudolphe ^a   Mareel, Marc M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Laboratory M Nuytinck   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DIMETHYL SULFOXIDE; DRINKING WATER; FLAVONOID; SOLVENT; TAMOXIFEN CITRATE; TANGERETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0033577042     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.4.354     Document Type: Article

References (29)

1. Early Breast Cancer Trialist's Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 relapses and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15;71-85.
2. Clarke R, Lippman ME. Antiestrogens resistance: mechanisms and reversal. In: Teicher BA, editor. Drug resistance in oncology. New York (NY): Marcel Dekker; 1992. p. 501-36.
3. Clarke R, Lippman ME. Mechanisms of resistance to antiestrogens and their implications for crossresistance. In: Kellen JA, editor. Tamoxifen: beyond the antiestrogen. Boston (MA): Birkhäuser; 1996. p. 93-122.
4. Wood AW, Smith DS, Chang RL, Huang MT, Conney AH. Effects of flavonoids on the metabolism of xenobiotics. In: Cody V, Middleton E Jr, Harborne JB, editors. Plant flavonoids in biology and medicine. New York (NY): Liss; 1986. p. 195-210.
5. Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM, Castronovo V. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res 1994;54: 4607-9.
6. Bracke ME, Bruyneel EA, Vermeulen SJ, Vennekens K, Van Marck V, Marcel MM. Citrus flavonoid effect on tumor invasion and metastases. Food Technol 1994;48:121-4.
7. Mareel M, Boterberg T, Noe V, Van Hoorde L, Vermeulen S, Bruyneel E, et al. E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion. J Cell Physiol 1997;173: 271-4.
8. Soule HD, Vazquez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973;51:1409-16.
9. Coopman P, Bracke M, Lissitzky JC, De Bruyne GK, Van Roy FM, Foidart JM, et al. Influence of basement membrane molecules on attachment and migration of human breast cell lines in vitro. J Cell Sci 1991;98: 395-401.
10. Bracke ME, Van Larebeke NA, Vyncke BM, Mareel MM. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro [published erratum appears in Br J Cancer 1992;65:486]. Br J Cancer 1991;63:867-72.
11. Bracke ME, Van Larebeke NA, Vyncke BM, Mareel MM. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro [published erratum appears in Br J Cancer 1992;65:486]. Br J Cancer 1991;63:867-72.
12. Correc P, Fondaneche MC, Bracke M, Burtin P. The presence of plasmin levels on three mammary carcinoma MCF-7 sublines. Int J Cancer 1990; 46:745-50.
13. Attia MA, Weiss DW. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 1966;26:1787-800.
14. DeGregorio MW, Wilbur BJ, Coronado E, Osborne CK. Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. Cancer Chemother Pharmacol 1987;20:316-8.
15. Kikuta C, Schmid R. Specific high-performance liquid chromatography analysis of tamoxifen and its major metabolites by "on-line" extraction and post-column photochemical reaction. J Pharm Biomed Anal 1989;7: 329-37.
16. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-12.
17. Dhooge CR, De Moerloose BM, Benoit YC, Van Roy N, Philippe J, Laureys GG. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma. Cancer 1997;80:1250-7.
18. Ivy SP, Olshefski RS, Taylor BJ, Patel KM, Reaman GH. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study. Blood 1996;88:309-18.
19. Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA. Lysis of fresh and cultured autologous tumor cells by human lymphocytes cultured in T-cell growth factor. Cancer Res 1981;41:4420-5.
20. Leclercq G, De Smedt M, Plum J. Direct evidence for partial target specificity in lymphokine-activated killer thymocytes. Scand J Immunol 1990; 32:373-9.
21. Screpanti I, Felli MP, Toniato E, Meco D, Martinotti S, Frati L, et al. Enhancement of natural-killer-cell susceptibility of human breast-cancer cells by estradiol and v-HA-ras oncogene. Int J Cancer 1991;47: 445-9.
22. Bracke ME, Vyncke BM, Bruyneel EA, Vermeulen SJ, De Bruyne GK, Van Larebeke NA, et al. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 1993;68:282-9.
23. Luini W, Boraschi D, Alberti S, Aleotti A, Tagliabue A. Morphological characterization of a cell population responsible for natural killer activity. Immunology 1981;43:663-8.
24. Welshons WV, Rottinghaus GE, Nonneman DJ, Dolan-Timpe M, Ross PF. A sensitive bioassay for detection of dietary estrogens in animal feeds. J Vet Diagn Invest 1990;2:268-73.
25. Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 1994;48: 1437-45.
26. Canivenc-Lavier MC, Vernevaut MF, Tous M, Siess MH. Magdalou J, Suschetet M. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology 1996;114: 19-27.
27. Baral E, Nagy E, Berczi I. Enhancement of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995;75:591-9.
28. Bracke ME, Vyncke B, De Pestel G, Vakaet L Jr, Bourgois L, Van Larebeke N, et al. Effect of flavonoids on cancer cell invasiveness. In: Das NP, editor. Flavonoids in biology and medicine. III. Current issues in flavonoid research. Singapore: National University of Singapore Press; 1989. p. 279-92.
29. Widmer WW, Montanari AM. The potential for citrus phytochemicals in hypernutritious foods. In: Finley JW, Armstrong DJ, Nagy S, Robinson SF, editors. Hypernutritious foods. Auburndale (FL): Agscience, Inc.; 1996. p. 75-89.